NASDAQ:ANPC
Delisted
AnPac Bio-Medical Science Co., Ltd. Stock News
$4.37
+0 (+0%)
At Close: Aug 18, 2023
AnPac Bio Makes Significant Progress in Detecting Pre-cancer Diseases and Recorded Over 20 Types of Pre-cancer Diseases
07:30am, Monday, 14'th Dec 2020
SAN JOSE, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and th
Anpac Bio Announces Change of Auditor
04:01pm, Friday, 04'th Dec 2020
SAN JOSE, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United
AnPac Bio-Medical Shares Rally Hard On Record Cancer Testing Volume
11:23am, Wednesday, 25'th Nov 2020
AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC) shares were advancing strongly Wednesday after the company reported strong third-quarter testing volume and issued a strong full-year outlook.�
Why These 3 Health Care Stocks Are Trading Higher Today
11:01am, Wednesday, 25'th Nov 2020
AIM ImmunoTech (NYSE: AIM) shares are trading higher on Wednesday after the company dosed its first patient in a study evaluating ampligen as part of combination treatment for patients with cancer and
AnPac Bio News: Why ANPC Stock Is Skyrocketing 110% Today
10:37am, Wednesday, 25'th Nov 2020
AnPac Bio (ANPC) news for Wednesday concerning performance during the company's third quarter of 2020 have ANPC stock on the rise. The post AnPac Bio News: Why ANPC Stock Is Skyrocketing 110% Today ap
AnPac Bio Sets Record Test Volume in Q3, and Forecasts ~ 100% Revenue Growth in 2020
07:30am, Wednesday, 25'th Nov 2020
SAN JOSE, Calif., Nov. 25, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in Chin
Anpac Bio Announces Appointment of New Independent Director
04:01pm, Monday, 16'th Nov 2020
SAN JOSE, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in Chin
AnPac Bio US Completes COVID-19 Antibody Test Verification and Approved to Begin Commercial Testing
07:30am, Tuesday, 10'th Nov 2020
SAN JOSE, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in Chin
SAN JOSE, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in Chin
Researchers Look for New Ways to Boost Diagnostic Capabilities
01:01pm, Friday, 02'nd Oct 2020
NEW YORK, Oct. 2, 2020 (PR Newswire Europe via COMTEX) --
NEW YORK, Oct. 2, 2020 /PRNewswire/ -- The global cancer diagnostics market is of the more...
Researchers Look for New Ways to Boost Diagnostic Capabilities
01:00pm, Friday, 02'nd Oct 2020
NEW YORK, Oct. 2, 2020 /PRNewswire via COMTEX/ --
NEW YORK, Oct. 2, 2020 /PRNewswire/ -- The global cancer diagnostics market is of the more innovative...
Lagos community petitions Sanwo-Olu over vandalism of electricity equipment | TheCable
04:21pm, Monday, 28'th Sep 2020
The community development association (CDA) of First Unity Estate, Badore, Ajah, has petitioned Babajide Sanwo-Olu, governor of Lagos state, over the vandalisation of electricity equipment in the comm
This DeFi Group Wants to Bring Maturity to the Yield Farming Craze - CoinDesk
01:00pm, Friday, 18'th Sep 2020
The Chicago DeFi Alliance, launched in April 2020, is now poised to help members profit from yield farming and the liquidity mining craze.
AnPac Bio-Medical Science Co., Ltd (ANPC) CEO Chris Yu on Q2 2020 Results - Earnings Call Transcript
12:08pm, Thursday, 10'th Sep 2020
AnPac Bio-Medical Science Co., Ltd. Q2 2020 Results Conference Call September 10, 2020 8:00 AM ET Company Participants Phil Case - Marketing and Investor Relations Chris Yu - Chairman & CEO Edward
AbbVie I-Mab Cancer Deal, And Other News: The Good, Bad And Ugly Of Biopharma
04:46am, Tuesday, 08'th Sep 2020
AbbVie inks multi-billion cancer deal with I-Mab. Chi-Med begins global phase III trial of cancer treatment.